PRAS40 (mouse) shRNA Citations (1)
Originally described in: PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.Wang L, Harris TE, Roth RA, Lawrence JC J Biol Chem. 2007 Jul 6. 282(27):20036-44. PubMed Journal
Articles Citing PRAS40 (mouse) shRNA
| Articles |
|---|
| p53 Inhibition Protects against Neuronal Ischemia/Reperfusion Injury by the p53/PRAS40/mTOR Pathway. Zhao J, Dong Y, Chen X, Xiao X, Tan B, Chen G, Hu J, Qi D, Li X, Xie R. Oxid Med Cell Longev. 2021 Dec 3;2021:4729465. doi: 10.1155/2021/4729465. eCollection 2021. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.